(EMAILWIRE.COM, July 14, 2015 ) Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into immunotherapies and BRAF mutation-targeted therapies. GlobalData estimates the 2013 sales for melanoma at approximately $1.34 billion across…
http://www.emailwire.com/release/192145-PharmaPoint-Melanoma-Global-Drug-Forecast-and-Market-Analysis-to-2023-Researchmoz.html
PharmaPoint: Melanoma – Global Drug Forecast and Market Analysis to 2023 | Researchmoz
Related Posts
Recent News
About Us
Market Press Newswire™ provides press release distribution services for businesses,organizations that provide market research reports. The press releases are published
across the webs. Other services include press release writing, editing,consulting and media planning.
Recent Post
Recent Posts
- $128.6 Billion by 2032 — Standalone Headsets Lead the VR Gaming Explosion
- $22.4 Billion by 2032 — Why the 32-Inch Format Dominates Smart Homes & Industrial HMIs
- $168.5 Billion by 2032 — Unified Commerce Drives the Next-Generation POS Revolution
- $9.8 Billion by 2032 — How Automated Vehicle Barriers Are Reshaping Perimeter Security
Contact Us
MarketPressNewswire.net™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC